RMD Stock Overview
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
ResMed Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$218.06 |
| 52 Week High | US$243.52 |
| 52 Week Low | US$132.24 |
| Beta | 0.67 |
| 1 Month Change | 11.07% |
| 3 Month Change | 14.68% |
| 1 Year Change | -9.50% |
| 3 Year Change | 16.01% |
| 5 Year Change | 93.52% |
| Change since IPO | 32,355.44% |
Recent News & Updates
ResMed Inc.'s (NYSE:RMD) Popularity With Investors Is Clear
Apr 18
With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting Case
Mar 22Capital Investments At ResMed (NYSE:RMD) Point To A Promising Future
Mar 10Recent updates
ResMed Inc.'s (NYSE:RMD) Popularity With Investors Is Clear
Apr 18With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting Case
Mar 22Capital Investments At ResMed (NYSE:RMD) Point To A Promising Future
Mar 10An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 30% Undervalued
Feb 12Why ResMed Is One Of My Top Picks In 2024
Jan 22A First Look At ResMed
Jan 09ResMed Inc.'s (NYSE:RMD) Share Price Could Signal Some Risk
Dec 20Why You Should Care About ResMed's (NYSE:RMD) Strong Returns On Capital
Dec 06Shareholders May Find It Hard To Justify Increasing ResMed Inc.'s (NYSE:RMD) CEO Compensation For Now
Nov 10Are Investors Undervaluing ResMed Inc. (NYSE:RMD) By 41%?
Nov 01ResMed: Weight-Loss Drug Worries Provide Buying Opportunity
Oct 28ResMed: Stock Re-Rating To 20x Forward P/E Is A Buy Opportunity
Sep 12ResMed Has Become A Steal (Rating Upgrade)
Aug 10ResMed's (NYSE:RMD) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 07ResMed (NYSE:RMD) Has Some Way To Go To Become A Multi-Bagger
Jul 30Here's Why We Think ResMed (NYSE:RMD) Might Deserve Your Attention Today
Jul 16Compound Your Wealth With ResMed
Jul 04A Look At The Fair Value Of ResMed Inc. (NYSE:RMD)
Jul 02We Think ResMed (NYSE:RMD) Can Stay On Top Of Its Debt
May 26ResMed (NYSE:RMD) Could Be Struggling To Allocate Capital
Apr 24Here's Why ResMed (NYSE:RMD) Has Caught The Eye Of Investors
Apr 09A Look At The Intrinsic Value Of ResMed Inc. (NYSE:RMD)
Mar 26ResMed goes ex dividend tomorrow
Feb 07ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Feb 06ResMed: The GARP Story Continues, Technicals Showing Vital Signs
Jan 26Why The 23% Return On Capital At ResMed (NYSE:RMD) Should Have Your Attention
Jan 23We Ran A Stock Scan For Earnings Growth And ResMed (NYSE:RMD) Passed With Ease
Dec 28Calculating The Fair Value Of ResMed Inc. (NYSE:RMD)
Dec 16ResMed: Strong Earnings Growth Supports The High Valuation, Unclear Technical Trends
Nov 14ResMed declares $0.44 dividend
Oct 27These 4 Measures Indicate That ResMed (NYSE:RMD) Is Using Debt Reasonably Well
Oct 22ResMed raised to Buy at BofA citing Q1 beat
Oct 20Shareholder Returns
| RMD | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 21.9% | 2.1% | 2.9% |
| 1Y | -9.5% | -1.9% | 22.2% |
Return vs Industry: RMD underperformed the US Medical Equipment industry which returned -1.4% over the past year.
Return vs Market: RMD underperformed the US Market which returned 21.9% over the past year.
Price Volatility
| RMD volatility | |
|---|---|
| RMD Average Weekly Movement | 6.7% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: RMD has not had significant price volatility in the past 3 months.
Volatility Over Time: RMD's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 10,140 | Mick Farrell | www.resmed.com |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes.
ResMed Inc. Fundamentals Summary
| RMD fundamental statistics | |
|---|---|
| Market cap | US$32.03b |
| Earnings (TTM) | US$958.38m |
| Revenue (TTM) | US$4.58b |
33.4x
P/E Ratio7.0x
P/S RatioIs RMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RMD income statement (TTM) | |
|---|---|
| Revenue | US$4.58b |
| Cost of Revenue | US$1.99b |
| Gross Profit | US$2.59b |
| Other Expenses | US$1.63b |
| Earnings | US$958.38m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.52 |
| Gross Margin | 56.51% |
| Net Profit Margin | 20.91% |
| Debt/Equity Ratio | 21.7% |
How did RMD perform over the long term?
See historical performance and comparison